Analyst Price Targets — CVS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 15, 2026 10:17 am | — | Robert W. Baird | $94.00 | $77.62 | TheFly | CVS Health price target raised to $94 from $92 at Baird |
| March 5, 2026 3:24 pm | Michael Cherny | Leerink Partners | $98.00 | $79.49 | StreetInsider | Leerink Partners Reiterates Outperform Rating on CVS Health (CVS), partnership with Google Cloud "positive AI development" |
| January 28, 2026 1:09 pm | — | Argus Research | $90.00 | $73.21 | TheFly | CVS Health price target lowered to $90 from $91 at Argus |
| January 6, 2026 1:49 pm | — | Bernstein | $91.00 | $80.57 | TheFly | CVS Health price target raised to $91 from $87 at Bernstein |
| December 12, 2025 11:40 am | — | Bernstein | $87.00 | $80.84 | TheFly | CVS Health price target raised to $87 from $86 at Bernstein |
| December 10, 2025 1:11 pm | Ann Hynes | Mizuho Securities | $95.00 | $79.05 | TheFly | CVS Health price target raised to $95 from $88 at Mizuho |
| December 10, 2025 12:15 pm | — | Robert W. Baird | $92.00 | $78.24 | TheFly | CVS Health price target raised to $92 from $82 at Baird |
| December 10, 2025 11:47 am | Jessica Tassan | Piper Sandler | $101.00 | $78.24 | TheFly | CVS Health price target raised to $101 from $99 at Piper Sandler |
| December 10, 2025 11:46 am | — | Morgan Stanley | $93.00 | $78.24 | TheFly | CVS Health price target raised to $93 from $89 at Morgan Stanley |
| December 10, 2025 11:25 am | — | Barclays | $93.00 | $78.24 | TheFly | CVS Health price target raised to $93 from $87 at Barclays |
Latest News for CVS
“Prudent portfolios include an element of ballast,” Jefferies analysts said on Tuesday in a research note.
Merit Financial Group LLC grew its position in shares of CVS Health Corporation (NYSE: CVS) by 27.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 53,512 shares of the pharmacy operator's stock after purchasing an additional
Benson Investment Management Company Inc. acquired a new stake in CVS Health Corporation (NYSE: CVS) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 74,870 shares of the pharmacy operator's stock, valued at approximately $5,942,000. CVS Health accounts for approximately 2.1%
CVS Health has a far more diversified business than Novo Nordisk. Both approaches have perks and disadvantages.
More than 500 CVS Health drivers and warehouse workers at the healthcare conglomerate's Fredericksburg, Virginia distribution center have voted to authorize a strike on May 1, the International Brotherhood of Teamsters said on Thursday.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.